Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07965081981 Ext: 4 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Aspira Pathlab & Diagnostics Limited plans to raise up to Rs 65,00,00,000 through a rights issue to eligible equity shareholders, potentially offering equity or convertible instruments, subject to shareholder and regulatory approvals, with the issue price, entitlement ratio, and record date to be determined later. The board has also constituted a Right Issue Committee, comprised of Mr. Nikunj Velji Mange (Chairman), Mr. Vaibhav Odhekar, Mrs. Kiran Raghavendra awasthi, and Mr. Balkrishna Subhash Talawadekar, to finalize the terms and conditions of the rights offering.